UBS OCONNOR LLC - PROTALIX BIOTHERAPEUTICS INC ownership

PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A309. A total of 33 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.82 and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS OCONNOR LLC ownership history of PROTALIX BIOTHERAPEUTICS INC
ValueSharesWeighting
Q1 2021$1,985,000,000
+264.9%
445,171
+196.8%
0.03%
+163.6%
Q4 2020$544,000,000
-53.1%
150,000
-50.0%
0.01%
-62.1%
Q3 2020$1,161,000,000
-54.4%
300,000
-55.4%
0.03%
-48.2%
Q2 2020$2,547,000,000672,0350.06%
Other shareholders
PROTALIX BIOTHERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Burrage Capital Management LLC 2,470,332$8,967,0006.83%
Psagot Value Holdings Ltd. 470,255$1,707,0000.04%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 212,591$772,0000.02%
UBS OCONNOR LLC 150,000$544,000,0000.01%
GSA CAPITAL PARTNERS LLP 10,042$36,0000.01%
Renaissance Technologies 488,634$1,774,0000.00%
Squarepoint Ops LLC 22,068$80,0000.00%
BANK OF AMERICA CORP /DE/ 222$1,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 50,280$183,0000.00%
View complete list of PROTALIX BIOTHERAPEUTICS INC shareholders